Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Irritable Bowel Syndrome, April 2018

Free Subscription


Abstracts

Retrieve all available abstracts of the following 79 articles:
HTML format


 

Single Articles

  1. HILZ MJ, Arbustini E, Dagna L, Gasbarrini A, et al
    Non-specific gastrointestinal features: Could it be Fabry disease?
    Dig Liver Dis. 2018 Mar 1. pii: S1590-8658(18)30209.
    Abstract    

    Abstract available

  2. HANNA A, Hanna LA
    What, where and when? Using Google Trends and Google to investigate patient needs and inform pharmacy practice.
    Int J Pharm Pract. 2018 Mar 30. doi: 10.1111/ijpp.12445.
    Abstract    

    Abstract available

  3. ALMARIO CV, Noah BD, Jusufagic A, Lew D, et al
    Cost-Effectiveness of Biomarker Tests for Irritable Bowel Syndrome with Diarrhea - A Framework for Payers.
    Clin Gastroenterol Hepatol. 2018 Mar 26. pii: S1542-3565(18)30281.
    Abstract    

    Abstract available

  4. LI Z, Huang W, Wang X, Zhang Y, et al
    The relationship between lower urinary tract symptoms and irritable bowel syndrome: a meta-analysis of cross-sectional studies.
    Minerva Urol Nefrol. 2018 Mar 28. pii: S0393-2249.18.03044.
    Abstract    

    Abstract available

  5. LEVENTOGIANNIS K, Gkolfakis P, Spithakis G, Tsatali A, et al
    Correction to: Effect of a Preparation of Four Probiotics on Symptoms of Patients with Irritable Bowel Syndrome: Association with Intestinal Bacterial Overgrowth.
    Probiotics Antimicrob Proteins. 2018 Mar 28. pii: 10.1007/s12602-018-9412.
    Abstract    

    Abstract available

  6. BERGER J, Carroll MP Jr, Champoux E, Coop CA, et al
    Extremely Delayed Diagnosis of Type II Hereditary Angioedema: Case Report and Review of the Literature.
    Mil Med. 2018 Mar 26. pii: 4954103. doi: 10.1093.
    Abstract    

    Abstract available

  7. TAN TK, Saps M, Lin CL, Wei CC, et al
    Risks of irritable bowel syndrome in children with infantile urinary tract infection: a 13-year nationwide cohort study.
    J Investig Med. 2018 Mar 26. pii: jim-2017-000703. doi: 10.1136/jim-2017-000703.
    Abstract    

    Abstract available

  8. KOGAWA AC, Salgado HRN
    Status of Rifaximin: A Review of Characteristics, Uses and Analytical Methods.
    Crit Rev Anal Chem. 2018 Mar 26:1-8. doi: 10.1080/10408347.2018.1447355.
    Abstract    

    Abstract available

  9. COSSERAT J, Du Breuil F, Validire P, Lenoir S, et al
    [Recurrent abdominal pain in an 88-year-old woman].
    Rev Med Interne. 2018 Mar 22. pii: S0248-8663(17)30568.
    Abstract    



  10. BELLINI M, Gambaccini D, Salvadori S, Bocchini R, et al
    Different perception of chronic constipation between patients and gastroenterologists.
    Neurogastroenterol Motil. 2018 Mar 25:e13336. doi: 10.1111/nmo.13336.
    Abstract    

    Abstract available

  11. BRENNER DM, Dove LS, Andrae DA, Covington PS, et al
    Radar plots: A novel modality for displaying disparate data on the efficacy of eluxadoline for the treatment of irritable bowel syndrome with diarrhea.
    Neurogastroenterol Motil. 2018 Mar 25:e13331. doi: 10.1111/nmo.13331.
    Abstract    

    Abstract available

  12. POLSTER A, Friberg P, Gunterberg V, Ohman L, et al
    Heart rate variability characteristics of patients with irritable bowel syndrome and associations with symptoms.
    Neurogastroenterol Motil. 2018 Mar 25:e13320. doi: 10.1111/nmo.13320.
    Abstract    

    Abstract available

  13. HENRICH JF, Martin M
    Altered attentional control linked to catastrophizing in patients with irritable bowel syndrome.
    Br J Health Psychol. 2018 Mar 23. doi: 10.1111/bjhp.12307.
    Abstract    

    Abstract available

  14. KWON S, Hsieh YS, Shin YK, Kang P, et al
    Linalyl acetate prevents olmesartan-induced intestinal hypermotility mediated by interference of the sympathetic inhibitory pathway in hypertensive rat.
    Biomed Pharmacother. 2018;102:362-368.
    Abstract    

    Abstract available

  15. HOLTON KF, Cotter EW
    Could dietary glutamate be contributing to the symptoms of obsessive-compulsive disorder?
    Future Sci OA. 2018;4:FSO277.
    Abstract    

    Abstract available

  16. PIRKOLA L, Laatikainen R, Loponen J, Hongisto SM, et al
    Low-FODMAP vs regular rye bread in irritable bowel syndrome: Randomized SmartPill((R)) study.
    World J Gastroenterol. 2018;24:1259-1268.
    Abstract    

    Abstract available

  17. KAMUDA JA, Mazzola N
    Plecanatide (Trulance) for Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation.
    P T. 2018;43:207-232.
    Abstract    

    Abstract available

  18. LANGSHAW AH, Rosen JM, Pensabene L, Borrelli O, et al
    Overlap between functional abdominal pain disorders and organic diseases in children.
    Rev Gastroenterol Mex. 2018 Apr 2. pii: S0375-0906(18)30052.
    Abstract    

    Abstract available

  19. SHIN SP, Choi YM, Kim WH, Hong SP, et al
    A double blind, placebo-controlled, randomized clinical trial that breast milk derived-Lactobacillus gasseri BNR17 mitigated diarrhea-dominant irritable bowel syndrome.
    J Clin Biochem Nutr. 2018;62:179-186.
    Abstract    

    Abstract available

  20. NILAND B, Cash BD
    Health Benefits and Adverse Effects of a Gluten-Free Diet in Non-Celiac Disease Patients.
    Gastroenterol Hepatol (N Y). 2018;14:82-91.
    Abstract    

    Abstract available

  21. SHAH ED, Almario CV, Spiegel BMR, Chey WD, et al
    Lower and Upper Gastrointestinal Symptoms Differ Between Individuals With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation.
    J Neurogastroenterol Motil. 2018;24:299-306.
    Abstract    

    Abstract available

  22. FARHADI A, Banton D, Keefer L
    Connecting Our Gut Feeling and How Our Gut Feels: The Role of Well-being Attributes in Irritable Bowel Syndrome.
    J Neurogastroenterol Motil. 2018;24:289-298.
    Abstract    

    Abstract available

  23. KIM SY, Choung RS, Lee SK, Choe JW, et al
    Self-reported Sleep Impairment in Functional Dyspepsia and Irritable Bowel Syndrome.
    J Neurogastroenterol Motil. 2018;24:280-288.
    Abstract    

    Abstract available

  24. SONG KH, Jung HK, Kim HJ, Koo HS, et al
    Clinical Practice Guidelines for Irritable Bowel Syndrome in Korea, 2017 Revised Edition.
    J Neurogastroenterol Motil. 2018;24:197-215.
    Abstract    

    Abstract available

  25. JANG SH, Kim YS
    Could Improvement in Subjective Well-being Relieve Gastrointestinal Symptoms in Patients With Irritable Bowel Syndrome?
    J Neurogastroenterol Motil. 2018;24:164-165.
    Abstract    



  26. KIM Y, Choi CH
    Role of Fructose Malabsorption in Patients With Irritable Bowel Syndrome.
    J Neurogastroenterol Motil. 2018;24:161-163.
    Abstract    



  27. UCHIYAMA-TANAKA Y
    Case Study of Homeopathic Bowel Nosode Remedies for Dysbiotic Japanese Patients.
    J Altern Complement Med. 2018;24:187-192.
    Abstract    

    Abstract available

  28. BALLOU S, Beath A, Kaptchuk TJ, Hirsch W, et al
    Factors Associated With Response to Placebo in Patients With Irritable Bowel Syndrome and Constipation.
    Clin Gastroenterol Hepatol. 2018 Apr 11. pii: S1542-3565(18)30345.
    Abstract    

    Abstract available

  29. WANG B, Duan R, Duan L
    Prevalence of sleep disorder in irritable bowel syndrome: A systematic review with meta-analysis.
    Saudi J Gastroenterol. 2018 Apr 13. pii: 229992.
    Abstract    

    Abstract available

  30. GARCIA-MARTINEZ I, Weiss TR, Yousaf MN, Ali A, et al
    A leukocyte activation test identifies food items which induce release of DNA by innate immune peripheral blood leucocytes.
    Nutr Metab (Lond). 2018;15:26.
    Abstract    

    Abstract available

  31. CHAO G, Wang Y, Zhang S, Yang W, et al
    Correction: MicroRNA-29a increased the intestinal membrane permeability of colonic epithelial cells in irritable bowel syndrome rats.
    Oncotarget. 2018;9:15816.
    Abstract    

    Abstract available

  32. LONG Y, Du L, Kim JJ, Chen B, et al
    MLCK-mediated intestinal permeability promotes immune activation and visceral hypersensitivity in PI-IBS mice.
    Neurogastroenterol Motil. 2018 Apr 11:e13348. doi: 10.1111/nmo.13348.
    Abstract    

    Abstract available

  33. ZHU SW, Liu ZJ, Li M, Zhu HQ, et al
    [Comparison of gut microbiotal compositional analysis of patients with irritable bowel syndrome through different bioinformatics pipelines].
    Beijing Da Xue Xue Bao Yi Xue Ban. 2018;50:231-238.
    Abstract    

    Abstract available

  34. HOLLERAN G, Scaldaferri F, Ianiro G, Lopetuso L, et al
    Fecal microbiota transplantation for the treatment of patients with ulcerative colitis and other gastrointestinal conditions beyond Clostridium difficile infection: an update.
    Drugs Today (Barc). 2018;54:123-136.
    Abstract    

    Abstract available

  35. EL AMROUSY D, Hassan S, El Ashry H, Yousef M, et al
    Vitamin D supplementation in adolescents with irritable bowel syndrome: Is it useful? A randomized controlled trial.
    Saudi J Gastroenterol. 2018;24:109-114.
    Abstract    

    Abstract available

  36. GUPTA S, Schaffer G, Saps M
    Pediatric Irritable Bowel Syndrome and Other Functional Abdominal Pain Disorders: An Update of Non-Pharmacological Treatments.
    Expert Rev Gastroenterol Hepatol. 2018.
    Abstract    

    Abstract available

  37. HEITKEMPER MM, Cain KC, Shulman RJ, Burr RL, et al
    Stool and urine trefoil factor 3 levels: associations with symptoms, intestinal permeability, and microbial diversity in irritable bowel syndrome.
    Benef Microbes. 2018 Apr 10:1-12. doi: 10.3920/BM2017.0059.
    Abstract    

    Abstract available

  38. LIU ZY, Gua X, Zhang RG, Wang XX, et al
    Association of mitochondrial displacement loop polymorphisms with IBS-D: a preliminary study.
    J Dig Dis. 2018 Apr 10. doi: 10.1111/1751-2980.12597.
    Abstract    

    Abstract available

  39. SCHMULSON MJ, Frati-Munari AC
    Bowel symptoms in patients that receive proton pump inhibitors. Results of a multicenter survey in Mexico.
    Rev Gastroenterol Mex. 2018 Apr 17. pii: S0375-0906(18)30062.
    Abstract    

    Abstract available

  40. BONFIGLIO F, Henstrom M, Nag A, Hadizadeh F, et al
    A GWAS meta-analysis from 5 population-based cohorts implicates ion channel genes in the pathogenesis of irritable bowel syndrome.
    Neurogastroenterol Motil. 2018 Apr 19:e13358. doi: 10.1111/nmo.13358.
    Abstract    

    Abstract available

  41. KANADA Y, Katayama A, Ikemoto H, Takahashi K, et al
    Inhibitory effect of the Kampo medicinal formula Yokukansan on acute stress-induced defecation in rats.
    Neuropsychiatr Dis Treat. 2018;14:937-944.
    Abstract    

    Abstract available

  42. OH AR, Sohn S, Lee J, Park JM, et al
    ChREBP deficiency leads to diarrhea-predominant irritable bowel syndrome.
    Metabolism. 2018 Apr 15. pii: S0026-0495(18)30106.
    Abstract    

    Abstract available

  43. SHUTKEVER O, Gracie DJ, Young C, Wood HM, et al
    No Significant Association Between the Fecal Microbiome and the Presence of Irritable Bowel Syndrome-type Symptoms in Patients with Quiescent Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Apr 13. pii: 4970060. doi: 10.1093.
    Abstract    

    Abstract available

  44. ZENG L, Li K, Wei H, Hu J, et al
    A Novel EphA2 Inhibitor Exerts Beneficial Effects in PI-IBS in Vivo and in Vitro Models via Nrf2 and NF-kappaB Signaling Pathways.
    Front Pharmacol. 2018;9:272.
    Abstract    

    Abstract available

  45. LOSURDO G, Principi M, Iannone A, Amoruso A, et al
    Extra-intestinal manifestations of non-celiac gluten sensitivity: An expanding paradigm.
    World J Gastroenterol. 2018;24:1521-1530.
    Abstract    

    Abstract available

  46. DONOVAN E, Martin SR, Lung K, Evans S, et al
    Pediatric Irritable Bowel Syndrome: Perspectives on Pain and Adolescent Social Functioning.
    Pain Med. 2018 Apr 5. pii: 4961335. doi: 10.1093.
    Abstract    

    Abstract available

  47. POHL D, Van Oudenhove L, Tornblom H, Le Neve B, et al
    Functional Dyspepsia and Severity of Psychologic Symptoms Associate With Postprandial Symptoms in Patients With Irritable Bowel Syndrome.
    Clin Gastroenterol Hepatol. 2018 Apr 24. pii: S1542-3565(18)30395.
    Abstract    

    Abstract available

  48. CHANG JY, Almazar AE, Richard Locke G 3rd, Larson JJ, et al
    Quantifying Rome symptoms for diagnosis of the irritable bowel syndrome.
    Neurogastroenterol Motil. 2018 Apr 27:e13356. doi: 10.1111/nmo.13356.
    Abstract    

    Abstract available

  49. FUKUDO S, Nakajima A, Fujiyama Y, Kosako M, et al
    Randomized, double-blind, placebo-controlled study vs data in the daily practice using linaclotide in patients with irritable bowel syndrome with constipation.
    Neurogastroenterol Motil. 2018;30:e13363.
    Abstract    



  50. SHEARER J, Paine P, Agrawal A, Ford AC, et al
    Efficacy of linaclotide in irritable bowel syndrome with constipation: Real-world data.
    Neurogastroenterol Motil. 2018;30:e13328.
    Abstract    



  51. COLLIGNON O, Petavy F
    Statistical considerations about the design and endpoints of randomized clinical trials for children with irritable bowel syndrome.
    Neurogastroenterol Motil. 2018;30:e13266.
    Abstract    



  52. SAPS M, Lavigne JV, van Tilburg MA, Miranda A, et al
    Endpoints, reliability, and meaningful changes in clinical trials for children with irritable bowel syndrome. The Rome foundation pediatric subcommittee on clinical trials.
    Neurogastroenterol Motil. 2018;30:e13308.
    Abstract    



  53. WEAVER KR, Melkus GE, Fletcher J, Henderson WA, et al
    Serum Proteomics in African American Female Patients With Irritable Bowel Syndrome: An Exploratory Study.
    Nurs Res. 2018;67:261-267.
    Abstract    

    Abstract available

  54. SUDHA MR, Jayanthi N, Aasin M, Dhanashri RD, et al
    Efficacy of Bacillus coagulans Unique IS2 in treatment of irritable bowel syndrome in children: a double blind, randomised placebo controlled study.
    Benef Microbes. 2018 Apr 26:1-10. doi: 10.3920/BM2017.0129.
    Abstract    

    Abstract available

  55. ENCK P, Mazurak N
    Dysbiosis in Functional Bowel Disorders.
    Ann Nutr Metab. 2018;72:296-306.
    Abstract    

    Abstract available

  56. CHEN AGY, Offereins MSL, Mulder CJ, Frampton CM, et al
    A Pilot Study of the Effect of Green Kiwifruit on Human Intestinal Fermentation Measured by Hydrogen and Methane Breath Testing.
    J Med Food. 2018 Apr 25. doi: 10.1089/jmf.2018.4179.
    Abstract    

    Abstract available

  57. KODANI M, Fukui H, Tomita T, Oshima T, et al
    Association between gastrointestinal motility and macrophage/mast cell distribution in mice during the healing stage after DSSinduced colitis.
    Mol Med Rep. 2018 Apr 24. doi: 10.3892/mmr.2018.8926.
    Abstract    

    Abstract available

  58. ZWEIG A, Schindler V, Becker AS, van Maren A, et al
    Higher prevalence of joint hypermobility in constipation predominant irritable bowel syndrome.
    Neurogastroenterol Motil. 2018 Apr 23:e13353. doi: 10.1111/nmo.13353.
    Abstract    

    Abstract available

  59. AASBRENN M, Lydersen S, Farup PG
    A Conservative Weight Loss Intervention Relieves Bowel Symptoms in Morbidly Obese Subjects with Irritable Bowel Syndrome: A Prospective Cohort Study.
    J Obes. 2018;2018:3732753.
    Abstract    

    Abstract available

  60. BARANGUAN CASTRO ML, Ros Arnal I, Garcia Romero R, Rodriguez Martinez G, et al
    [Implementationof a low FODMAP dietforfunctional abdominal pain].
    An Pediatr (Barc). 2018 Apr 20. pii: S1695-4033(18)30135.
    Abstract    

    Abstract available

  61. GEIJO MARTINEZ F, Sanchez Garrido A, Marcos Prieto H, Pineiro Perez C, et al
    Long-term results of linaclotide in the treatment of constipation-type irritable bowel syndrome.
    Rev Esp Enferm Dig. 2018;110.
    Abstract    

    Abstract available

  62. KUROKAWA S, Kishimoto T, Mizuno S, Masaoka T, et al
    The effect of fecal microbiota transplantation on psychiatric symptoms among patients with irritable bowel syndrome, functional diarrhea and functional constipation: An open-label observational study.
    J Affect Disord. 2018;235:506-512.
    Abstract    

    Abstract available

  63. HE F, Wu C, Li P, Li N, et al
    Functions and Signaling Pathways of Amino Acids in Intestinal Inflammation.
    Biomed Res Int. 2018;2018:9171905.
    Abstract    

    Abstract available

  64. CARROZZINO D, Porcelli P
    Alexithymia in Gastroenterology and Hepatology: A Systematic Review.
    Front Psychol. 2018;9:470.
    Abstract    

    Abstract available

  65. ELSENBRUCH S, Labrenz F
    Nocebo Effects and Experimental Models in Visceral Pain.
    Int Rev Neurobiol. 2018;138:285-306.
    Abstract    

    Abstract available

  66. FORD AC
    Stool as a treatment for IBS: more questions than answers?
    Lancet Gastroenterol Hepatol. 2018;3:2-3.
    Abstract    



  67. VAN TILBURG MAL
    Can we treat visceral hypersensitivity in functional abdominal pain?
    Lancet Gastroenterol Hepatol. 2017 Aug 18. pii: S2468-1253(17)30258.
    Abstract    



  68. CLEVERS E, Vaes B, Henrard S, Goderis G, et al
    Health problems associated with irritable bowel syndrome: analysis of a primary care registry.
    Aliment Pharmacol Ther. 2018 Mar 24. doi: 10.1111/apt.14612.
    Abstract    

    Abstract available

  69. BONNERT M, Olen O, Bjureberg J, Lalouni M, et al
    The role of avoidance behavior in the treatment of adolescents with irritable bowel syndrome: A mediation analysis.
    Behav Res Ther. 2018;105:27-35.
    Abstract    

    Abstract available

  70. HELSEL BC, Williams JE, Lawson K, Liang J, et al
    Telemedicine and Mobile Health Technology Are Effective in the Management of Digestive Diseases: A Systematic Review.
    Dig Dis Sci. 2018 Apr 16. pii: 10.1007/s10620-018-5054.
    Abstract    

    Abstract available

  71. BONFIGLIO F, Zheng T, Garcia-Etxebarria K, Hadizadeh F, et al
    Female-specific Association Between Variants on Chromosome 9 and Self-reported Diagnosis of Irritable Bowel Syndrome.
    Gastroenterology. 2018 Apr 4. pii: S0016-5085(18)30407.
    Abstract    

    Abstract available

  72. CRAIG RM
    Low FODMAP Diet for IBS.
    Gastroenterology. 2018;154:1547.
    Abstract    



  73. LACKNER JM, Jaccard J, Keefer L, Brenner D, et al
    Improvement in Gastrointestinal Symptoms After Cognitive Behavior Therapy for Refractory Irritable Bowel Syndrome.
    Gastroenterology. 2018 Apr 24. pii: S0016-5085(18)30406.
    Abstract    

    Abstract available

  74. FRANCAVILLA R, Piccolo M, Francavilla A, Polimeno L, et al
    Clinical and Microbiological Effect of a Multispecies Probiotic Supplementation in Celiac Patients With Persistent IBS-type Symptoms: A Randomized, Double-Blind, Placebo-controlled, Multicenter Trial.
    J Clin Gastroenterol. 2018 Apr 23. doi: 10.1097/MCG.0000000000001023.
    Abstract    

    Abstract available

  75. GWEE KA, Lee WW, Ling KL, Ooi CJ, et al
    Consensus and contentious statements on the use of probiotics in clinical practice: a South East Asian Gastro-neuro Motility Association Working Team Report.
    J Gastroenterol Hepatol. 2018 Apr 26. doi: 10.1111/jgh.14268.
    Abstract    

    Abstract available

  76. THOMPSON DG, O'Brien S, Kennedy A, Rogers A, et al
    Radiation-induced enteropathy - how a low-FODMAP diet might help.
    Scand J Gastroenterol. 2018;53:377-378.
    Abstract    

    Abstract available

  77. BLACK CJ, Ford AC
    Defining the functional gastrointestinal disorders is challenging: are clinical symptoms alone sufficient?
    Scand J Gastroenterol. 2018;53:140.
    Abstract    



  78. ZOLLER B, Ohlsson H, Waehrens R, Sundquist J, et al
    Association of irritable bowel syndrome and venous thromboembolism.
    Scand J Gastroenterol. 2018 Apr 24:1-6. doi: 10.1080/00365521.2018.1465118.
    Abstract    

    Abstract available

  79. ZHU L, Ma Y, Deng X
    Comparison of acupuncture and other drugs for chronic constipation: A network meta-analysis.
    PLoS One. 2018;13:e0196128.
    Abstract    

    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Irritable Bowel Syndrome is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;